Envista Holdings Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Los beneficios de Envista Holdings han disminuido a una tasa media anual de -2.6%, mientras que en la industria Medical Equipment los beneficios crecieron en un 13.5% anualmente. Los ingresos han ido disminuyendo a una tasa media de 0.5% al año.
Información clave
-9.5%
Tasa de crecimiento de los beneficios
-11.4%
Tasa de crecimiento del BPA
| Crecimiento de la industria Medical Equipment | 8.9% |
| Tasa de crecimiento de los ingresos | 0.5% |
| Rentabilidad financiera | -2.9% |
| Margen neto | -4.7% |
| Última actualización de beneficios | 29 Mar 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Is There An Opportunity With Envista Holdings Corporation's (NYSE:NVST) 40% Undervaluation?
Apr 10
Envista Holdings (NYSE:NVST) Seems To Use Debt Quite Sensibly
Mar 06Envista Holdings: Rating Downgrade To Hold As Earnings Growth Is Going To Be Weak
Feb 14Returns On Capital At Envista Holdings (NYSE:NVST) Have Stalled
Feb 01Envista Holdings Corporation's (NYSE:NVST) Intrinsic Value Is Potentially 90% Above Its Share Price
Dec 26We Think Envista Holdings (NYSE:NVST) Can Stay On Top Of Its Debt
Nov 17Envista: Still Bullish Considering 2024 Outlook And Inorganic Growth Drivers
Oct 31Returns On Capital At Envista Holdings (NYSE:NVST) Have Hit The Brakes
Oct 27Is Now The Time To Look At Buying Envista Holdings Corporation (NYSE:NVST)?
Sep 25Envista: Consider Revenue Mix And Portfolio Transformation
Aug 22Envista Holdings (NYSE:NVST) Seems To Use Debt Quite Sensibly
Aug 14Returns At Envista Holdings (NYSE:NVST) Appear To Be Weighed Down
Jul 28Envista Holdings Corporation (NYSE:NVST) Shares Could Be 28% Below Their Intrinsic Value Estimate
Jun 28What Is Envista Holdings Corporation's (NYSE:NVST) Share Price Doing?
Jun 09Envista: Weakness In 1Q23 Should Be Done And Dusted
Jun 07We Think Envista Holdings (NYSE:NVST) Can Stay On Top Of Its Debt
May 09Here's What To Make Of Envista Holdings' (NYSE:NVST) Decelerating Rates Of Return
Apr 24Estimating The Intrinsic Value Of Envista Holdings Corporation (NYSE:NVST)
Mar 21Is It Time To Consider Buying Envista Holdings Corporation (NYSE:NVST)?
Mar 06Envista Non-GAAP EPS of $0.52 beats by $0.03, revenue of $660.8M beats by $2.4M
Feb 08Is Envista Holdings (NYSE:NVST) Using Too Much Debt?
Feb 03Envista: Positive Long-Term Outlook
Jan 31Envista Holdings' (NYSE:NVST) Returns Have Hit A Wall
Jan 19Are Investors Undervaluing Envista Holdings Corporation (NYSE:NVST) By 35%?
Dec 20What Does Envista Holdings Corporation's (NYSE:NVST) Share Price Indicate?
Dec 05Envista Non-GAAP EPS of $0.47 in-line, revenue of $631.1M beats by $1.32M
Nov 03Is Envista Holdings (NYSE:NVST) Using Too Much Debt?
Nov 03Envista Holdings (NYSE:NVST) Hasn't Managed To Accelerate Its Returns
Oct 16Is Envista Holdings Corporation (NYSE:NVST) Trading At A 39% Discount?
Sep 10Envista stock rises after Piper Sandler raises rating to overweight
Aug 29Is It Too Late To Consider Buying Envista Holdings Corporation (NYSE:NVST)?
Aug 23Envista Holdings: Not Sinking My Teeth In Yet
Jul 18These 4 Measures Indicate That Envista Holdings (NYSE:NVST) Is Using Debt Safely
Jul 12Envista Holdings Corporation (NYSE:NVST) Shares Could Be 38% Below Their Intrinsic Value Estimate
Jun 03Here's What To Make Of Envista Holdings' (NYSE:NVST) Decelerating Rates Of Return
May 13What Does Envista Holdings Corporation's (NYSE:NVST) Share Price Indicate?
Apr 01Is Envista Holdings (NYSE:NVST) Using Too Much Debt?
Mar 14Envista Holdings Corporation's (NYSE:NVST) Intrinsic Value Is Potentially 47% Above Its Share Price
Feb 24Envista Holdings (NYSE:NVST) Might Have The Makings Of A Multi-Bagger
Feb 07Envista Holdings: Not Making A Dent
Dec 25Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero Envista Holdings. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 29 Mar 24 | 2,563 | -120 | 1,046 | 93 |
| 31 Dec 23 | 2,567 | -100 | 1,029 | 94 |
| 29 Sep 23 | 2,582 | 191 | 1,024 | 98 |
| 30 Jun 23 | 2,582 | 219 | 1,030 | 102 |
| 31 Mar 23 | 2,565 | 211 | 1,023 | 100 |
| 31 Dec 22 | 2,569 | 238 | 1,014 | 100 |
| 30 Sep 22 | 2,560 | 207 | 1,044 | 100 |
| 01 Jul 22 | 2,536 | 238 | 1,028 | 98 |
| 01 Apr 22 | 2,528 | 272 | 1,011 | 99 |
| 31 Dec 21 | 2,509 | 264 | 990 | 101 |
| 01 Oct 21 | 2,473 | 312 | 924 | 99 |
| 02 Jul 21 | 2,413 | 256 | 894 | 95 |
| 02 Apr 21 | 1,995 | 122 | 805 | 78 |
| 31 Dec 20 | 1,929 | 43 | 859 | 87 |
| 02 Oct 20 | 2,033 | 8 | 910 | 99 |
| 03 Jul 20 | 2,145 | 46 | 948 | 115 |
| 03 Apr 20 | 2,639 | 163 | 1,055 | 146 |
| 31 Dec 19 | 2,285 | 184 | 970 | 133 |
| 27 Sep 19 | 2,790 | 213 | 1,055 | 163 |
| 28 Jun 19 | 2,810 | 215 | 1,061 | 169 |
| 29 Mar 19 | 2,832 | 232 | 1,066 | 174 |
| 31 Dec 18 | 2,845 | 231 | 1,113 | 172 |
| 31 Dec 17 | 2,811 | 301 | 1,033 | 172 |
| 31 Dec 16 | 2,785 | 272 | 1,034 | 143 |
Ingresos de calidad: NVST actualmente no es rentable.
Margen de beneficios creciente: NVST actualmente no es rentable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: NVST no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 2.6% al año.
Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de NVST en el último año con su promedio de 5 años, ya que actualmente no es rentable.
Beneficios vs. Industria: NVST no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Medical Equipment (3.3%).
Rentabilidad financiera
Alta ROE: NVST tiene una rentabilidad financiera negativa (-2.4%), ya que actualmente no es rentable.